- Investing Ideas
- Hong Kong Pharmaceuticals & Biotech Low P/E Dividend Stocks
Hong Kong Pharmaceuticals & Biotech Low P/E Dividend Stocks
Results
7
7 companies
Essex Bio-Technology
Market Cap: HK$1.5b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$2.76
7D
4.5%
1Y
-37.4%
Tong Ren Tang Technologies
Market Cap: HK$4.0b
Produces and distributes Chinese medicine products in Mainland China and Hong Kong.
1666
HK$3.23
7D
0.6%
1Y
-34.5%
China Shineway Pharmaceutical Group
Market Cap: HK$5.6b
An investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.
2877
HK$7.52
7D
-0.8%
1Y
-4.1%
Jacobson Pharma
Market Cap: HK$2.0b
Through its subsidiaries, engages in the research, development, production, sale, and distribution of medicine and drugs in Hong Kong, Mainland China, Macau, Singapore, and internationally.
2633
HK$1.04
7D
-5.5%
1Y
-36.2%
JBM (Healthcare)
Market Cap: HK$1.5b
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, Singapore, and internationally.
2161
HK$1.99
7D
-12.7%
1Y
-40.6%
Pak Fah Yeow International
Market Cap: HK$747.9m
An investment holding company, engages in manufacturing, marketing, and distributing healthcare products under the Hoe Hin brand name.
239
HK$2.40
7D
1.7%
1Y
-3.2%
Dawnrays Pharmaceutical (Holdings)
Market Cap: HK$1.5b
An investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally.
2348
HK$0.99
7D
-4.8%
1Y
-20.2%